- Report
- October 2023
- 193 Pages
Global
From €4898EUR$4,950USD£4,247GBP
- Report
- November 2022
- 145 Pages
Global
From €2473EUR$2,499USD£2,144GBP
- Report
- December 2022
- 169 Pages
Global
From €2474EUR$2,500USD£2,145GBP
- Report
- December 2022
- 145 Pages
Global
From €4452EUR$4,500USD£3,861GBP
- Report
- April 2023
- 157 Pages
Global
From €5244EUR$5,300USD£4,548GBP
- Report
- October 2023
- 93 Pages
Global
From €5541EUR$5,600USD£4,805GBP
- Report
- February 2023
- 250 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- August 2023
- 115 Pages
Global
From €4700EUR$4,750USD£4,076GBP
- Report
- March 2023
- 375 Pages
Global
From €11873EUR$12,000USD£10,296GBP
- Report
- June 2023
- 88 Pages
Global
From €5442EUR$5,500USD£4,719GBP
- Report
- July 2023
- 184 Pages
Global
From €3516EUR$3,554USD£3,050GBP
€3907EUR$3,949USD£3,388GBP
- Report
- July 2023
- 198 Pages
Global
From €3516EUR$3,554USD£3,050GBP
€3907EUR$3,949USD£3,388GBP
- Report
- July 2023
- 193 Pages
Global
From €3516EUR$3,554USD£3,050GBP
€3907EUR$3,949USD£3,388GBP
- Report
- June 2023
- 170 Pages
Global
From €5887EUR$5,950USD£5,105GBP
- Report
- May 2023
- 180 Pages
Global
From €5887EUR$5,950USD£5,105GBP
- Report
- October 2023
- 168 Pages
Global
From €5392EUR$5,450USD£4,676GBP
- Report
- October 2023
- 277 Pages
Global
From €5739EUR$5,800USD£4,977GBP
- Report
- April 2023
- 200 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- April 2023
- 400 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- February 2023
- 250 Pages
Global
From €4947EUR$5,000USD£4,290GBP

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more